[Dyslipidemia in diabetes mellitus]
- PMID: 11346913
[Dyslipidemia in diabetes mellitus]
Abstract
Patients with diabetes mellitus are at high risk of cardiovascular diseases. Dyslipidemia is an important risk factor for cardiovascular complications in diabetes. Increased triglyceride and reduced HDL-cholesterol plasma concentrations are common features of dyslipidemia in type 2 diabetes. The LDL particles are small and dense and have an increased atherogenity. Abnormalities in lipoprotein composition are observed in diabetes mellitus, especially in type 2. Post-hoc subgroup analyses of studies on the effect of lipid-lowering therapy on cardiovascular events suggest that treatment of dyslipidemia in diabetes may prevent cardiovascular complications. There are increasing indications that dyslipidemia in diabetes mellitus deserves aggressive treatment and that lipid target levels should be very low.
Similar articles
-
[Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):761-5. Ned Tijdschr Geneeskd. 2001. PMID: 11346911 Dutch.
-
Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.Indian Heart J. 2001 Mar-Apr;53(2):172-6. Indian Heart J. 2001. PMID: 11428472 Clinical Trial.
-
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003. Clin Ther. 2007. PMID: 17919548
-
Management of hypercholesterolaemia in the patient with diabetes.Int J Clin Pract Suppl. 2002 Jul;(130):27-32. Int J Clin Pract Suppl. 2002. PMID: 12296606 Review.
-
Diabetic dyslipidemia: extending the target beyond LDL cholesterol.Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S20-4. doi: 10.1097/01.hjr.0000368195.09485.17. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20489416 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical